Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
Healthcare
$2.00 +1.63%
+$0.10 today
- Market cap
- $109.62M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
52W Low $5.85High $33.68
Volume 0.86M
Average 0.66M
Balance Sheet
Inspect the capital base behind the business.
Assets
$353.77M
FY 2025 · Annual
-26.6% YoYLiabilities
$14.00M
FY 2025 · Annual
+18.0% YoYEquity
$339.77M
FY 2025 · Annual
-27.7% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $96.7M |
| Short-term Investments | $197.9M |
| Receivables | $1.0M |
| Other Current | $20.7M |
| Total Current Assets | $316.3M |
| PP&E (Net) | $1.6M |
| Other Non-current | $194.0K |
| Total Non-current Assets | $1.8M |
| Total Assets | $318.1M |
Analysis
Selected assets total $318.1M for Latest. The largest visible component is Short-term Investments at $197.9M, about 62.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 29, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 17, 2026 |
How much cash does UPB have?
Upstream Bio, Inc. (UPB) reported $101.58M in cash and equivalents in fiscal 2025.
How much debt does UPB carry?
Upstream Bio, Inc. (UPB) reported $1.27M of total debt, with net debt of -$100.31M.
Continue the stock analysis
Jump to another research area for this company.